Lepor H: Prostate selectivity of alpha-blockers: from receptor biology to clinical medicine. Eur Urol 29 (suppl 1): 12-16, 1996.Lepor H. Prostate selectivity of alpha blockers: From receptor biology to clinical medicine. Eur Urol 1996; 29: 12–16....
Alpha blockers (ABs) are frequently prescribed to patients with chronic kidney disease (CKD), which is often complicated by refractory hypertension (HT). Although there have been several reports on the association between AB use and the risk of fractures, their conclusions have not yet been drawn...
Beta-Blockers: Safe for Chronic Obstructive Pulmonary Disease? Inflammation Affects Association Between Furan Exposure and Chronic Obstructive Pulmonary Disease Drug Prototype Shows Promise for Stem Cell Treatment of Pulmonary Disease Distinct Comorbidity Clusters in Patients With Acute Heart Failure Geneti...
myelosuppression, however, may limit its use in some patients. IVIG and beta blockers may also have prophylactic roles to play by inhibiting leukocyte activation and the adhesion of sickled RBCs to vascular endothelium, respectively (Kanter and Kruse-Jarres 2013;Manwani and Frenette 2013). Pain c...
1 Guideline: Preoperative Medication Management Quick Guide for Preoperative Medication Management Medication Class Examples CONTINUE up to and including the day of surgery: Alpha1 Blockers Doxazosin, prazosin, tamsulosin Alpha2 Agonists Clonidine, guanfacine, methyldopa Antianxiet...
(2) drug risk factors, which include, birth control pills; hormones, such as estrogen, and corticosteroids; certain diuretics; and various D blockers; (3) dietary risk factors include dietary fat intake per total calories greater than 40%; saturated fat intake per total calories greater than ...
The doctor does not initially prescribe the strongest thing out there, but instead starts with a mild agent (e.g, a diuretic) and then increases the dose or may add another mild agent (e.g., a beta-blocker), and then start adding or substituting stronger medications. The same is true ...
The first drug approved in the U.S. was ipilimumab, a CTLA4 blocker, which was approved in 2011 [19]. However, CRC durable responses with PD1/PD-L1 inhibitors can be achieved in only approximately 40% of patients with MMR-deficient tumors; in patients with sporadic CRCs, it is unclear ...
Mariana-Ana Pali 2, Dumitru Cauni 2, Emma Adriana Ozon 1,*, Denisa Udeanu 1 , Simona Trifu 4 and Bogdana Adriana Năsui 5 1 Faculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, 6 Traian Vuia Street, 020945 Bucharest, Romania; ancapop@hotmail.com or anca.pop@umf...
Kim's ready room Kim assumed his first command when he took over a Kraylor medical transport, so-named Nightingale, during a conflict with the Annari. He believed that the ship was carrying medicine, but was really a prototype ship carrying a newly developed cloaking device. (VOY: "...